SecBot SecBot
EFFECT ·Filed Jun 22, 2026

CDIX

Cardiff Lexington Corp
BEARISH
Impact 7/10
Horizonweeks Processed4mo ago SEC9999999995-26-002069
IPO/offering going effective
Actionable Insight ▼ Bearish

The effectiveness of this S-1 opens the door for immediate share sales by the fund, which could pressure the stock price. Traders should monitor for any subsequent sales or announcements of draws on the facility, as the 97% discount structure suggests significant downward pressure on the stock. The going-concern warning indicates high risk of further distress.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CDIX ▼ -72.78% at T+60d
SHORT call ✓ call won +72.78% · α vs SPY +75.00% · entry $1.80 → $0.4899
Entry = T+0 close
Jun 22, 2026
via day close
T+1d
0.00%
call 0.00% · α -1.45%
$1.80
settled 4mo ago
T+5d
-5.56%
call +5.56% · α +5.10%
$1.70
settled 4mo ago
T+20d
-58.33%
call +58.33% · α +58.02%
$0.7500
settled 3mo ago
T+60d
-72.78%
call +72.78% · α +75.00%
$0.4899
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Cardiff Lexington Corp's registration statement on Form S-1 (File No. 333-296710) became effective on June 18, 2026, under the Securities Act of 1933. This effectiveness allows the company to proceed with the sale of up to 50,166,667 common shares to Leonite Fund I, LP under a stock purchase agreement, with the potential for severe dilution. The company is in a distressed financial state, as indicated by a going-concern opinion from its auditor.

Key Facts

  • EFFECT notice for S-1 registration statement (File No. 333-296710) became effective on June 18, 2026.
  • The S-1 registers up to 50,166,667 common shares for resale to Leonite Fund I, LP.
  • The stock purchase agreement allows the company to direct the fund to buy up to $75 million of its common stock at a 97% discount.
  • The offering represents potential dilution of 328% of current outstanding shares.
  • The company's auditor has issued a going-concern opinion, indicating material financial distress.
  • The company receives no proceeds from the resale but can draw up to $75 million for working capital.

Financial Impact

Potential dilution of 328% of current shares; up to $75 million in capital at a 97% discount to market price.

dilutionstock priceworking capital

Risk Factors

  • Severe dilution from the sale of shares at a 97% discount to market price.
  • Potential for stock price suppression as the fund sells shares.
  • Going-concern uncertainty may lead to further financial deterioration or restructuring.
  • Limited proceeds to the company from the resale; capital is only available if the company draws on the facility.

Market Snapshot

Exchange
OTC
Sector
Services-Offices & Clinics of Doctors of Medicine

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002069
Document: 9999999995-26-002069-index.html9999999995-26-002069
Document: 9999999995-26-002069.txt9999999995-26-002069
4 reports for CDIX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CDIX — sortable, filterable
TypeNow
Sep 4, 2026
7w ago
8-K
NEUTRAL ★ 2/10
$0.1162awaiting T+60—$0.0250 (−78.49%)
Jun 22, 2026
18w ago
EFFECT
BEARISH ★ 7/10
$1.80 $0.4899▲ +72.78%▲ +75.00%$0.0250 (+98.61%)
Jun 11, 2026
19w ago
S-1
BEARISH ★ 6/10
$1.40 $0.1162▲ +91.70%▲ +95.23%$0.0250 (+98.21%)
Jun 11, 2026
19w ago
8-K
BEARISH ★ 6/10
$1.40 $0.1162▲ +91.70%▲ +95.23%$0.0250 (+98.21%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 4h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 22, 2026